![Dominik Höchli](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dominik Höchli
Director/Board Member at
MOLECULAR PARTNERS AG
Net worth: 20 021 $ as of 2026-05-30
Profile
Currently, Dominik Höchli is an Independent Non-Executive Director at Molecular Partners AG since 2021 and a Director at Abivax SA starting in 2025.
Formerly, Dr. Höchli was Co-Managing Director at Catapult Therapeutics BV from 2021 to 2025 and Vice President & Head-Global Medical Affairs at AbbVie AG.
Education includes a doctorate from the University of Bern.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-12-30 | 4,982 ( 0.01% ) | 20 021 $ | 2026-05-30 |
Dominik Höchli active positions
| Companies | Position | Start |
|---|---|---|
| MOLECULAR PARTNERS AG | Director/Board Member | 2021-04-20 |
| ABIVAX | Director/Board Member | 2025-04-21 |
Former positions of Dominik Höchli
| Companies | Position | End |
|---|---|---|
Catapult Therapeutics BV
 Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company which develops cancer treatments | Chief Executive Officer | 2025-04-21 |
AbbVie AG
 AbbVie AG Miscellaneous Commercial ServicesCommercial Services Develops and markets therapies | Chief Tech/Sci/R&D Officer | - |
Training of Dominik Höchli
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
11
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Bern
 University of Bern Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Molecular Partners AG
 Molecular Partners AG BiotechnologyHealth Technology Engages in discovery, development and commercialization of biopharmaceutical products | Health Technology |
AbbVie AG
AbbVie AG Miscellaneous Commercial ServicesCommercial Services Develops and markets therapies | Commercial Services |
Abivax SA
 Abivax SA Pharmaceuticals: OtherHealth Technology Operates biotechnology company which develops therapeutics that harness the body’s natural regulatory mechanisms | Health Technology |
Catapult Therapeutics BV
Catapult Therapeutics BV Miscellaneous Commercial ServicesCommercial Services Operates as a biopharmaceutical company which develops cancer treatments | Commercial Services |
- Stock Market
- Insiders
- Dominik Höchli
